562aa1bb-figure-01 (562aa1bb Figure 01)
Chemical structure diagram of gabapentin, showing its cyclohexane ring bonded to amino and carboxymethyl groups.*
Gabapentin
Product Images NDC 16590-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 16590-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
562aa1bb-figure-02 (562aa1bb Figure 02)
A line graph depicting mean pain score over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The X-axis shows weeks from baseline to week 8, including a 4-week dose titration period and a 4-week fixed-dose period. The Y-axis represents mean pain scores from 0 to 10. Gabapentin group shows a decreasing pain score trend with statistically significant differences (p < 0.01) compared to placebo throughout the study.*
562aa1bb-figure-03 (562aa1bb Figure 03)
A line graph comparing mean pain scores over a 7-week period for placebo and two doses of gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents weeks including a 3-week dose titration and a 4-week fixed dose period; the y-axis shows mean pain scores. Both gabapentin groups show reduced mean pain scores compared to placebo throughout the study.*
562aa1bb-figure-04 (562aa1bb Figure 04)
A bar graph showing the percentage of responders at endpoint in two studies comparing placebo (PBO) and gabapentin (GBP) at different doses (3600, 1800, and 2400 mg). Study 1 shows 12% responders for placebo and 29% for GBP 3600 mg. Study 2 shows 14% responders for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*
562aa1bb-figure-05 (562aa1bb Figure 05)
A scatter plot comparing percentage difference against daily dose in milligrams. The chart includes three study groups labeled as STUDY a (black squares), STUDY b (checkered squares), and STUDY c (white squares). The x-axis shows daily dose values ranging from 600 to 1800 mg, and the y-axis indicates percentage difference from 2% to 22%. Individual data points from each study group are plotted with letter annotations near each point.*
562aa1bb-figure-06 (562aa1bb Figure 06)
GABAPENTIN 300 mg capsules in a white and gray blister pack with transparent pockets, labeled with STAT RX USA LLC. Each capsule is oval-shaped and white, with identifying imprint text on them. The packaging shows the product name, strength, dosage form, and labeler information clearly printed on the foil backing.*
562aa1bb-figure-07 (562aa1bb Figure 07)
The image shows a GABAPENTIN 300 mg capsule bottle label. The label includes the proprietary name GABAPENTIN and indicates a capsule dosage form with 300 mg strength. The labeler is STAT RX USA LLC. Bottle size and other details are not clearly visible.*
562aa1bb-figure-08 (562aa1bb Figure 08)
GABAPENTIN oral capsule bottle label from STAT RX USA LLC. The label shows GABAPENTIN prominently along with supplemental text and barcode details. The label includes dosage form indicated as capsules and standard pharmaceutical labeling elements.*
Label Image (Gabapentin 100mg Label)
GABAPENTIN 100 mg capsule label from STAT RX USA LLC, generic for Neurontin, containing 90 capsules. The label includes NDC 16590-101-90 and indicates the manufacturer as Actavis Elizabeth LLC, Elizabeth, NJ. The sample label also features storage instructions and a caution note regarding federal law restrictions.*
Label Image (Gabapentin 300mg Label)
Label for Gabapentin 300mg capsules, 90 count, generic for Neurontin, packaged and distributed by STAT RX USA LLC located in Gainesville, GA. The label includes the NDC 16590-102-90, manufacturer's details as Actavis Elizabeth LLC, Elizabeth, NJ, and storage instructions. It also features warnings about federal law and safety notices to keep out of reach of children.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
